Pharmaceuticals Ultrasector is trading at 34.04 as of the 21st of December 2025; that is 0.26 percent down since the beginning of the trading day. The fund's open price was 34.13. Pharmaceuticals Ultrasector has less than a 17 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. The performance scores are derived for the period starting the 22nd of September 2025 and ending today, the 21st of December 2025. Click here to learn more.
The fund invests in financial instruments that the fund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the pharmaceuticals segment of the SP Total Market Index, which comprises the following sub-industry pharmaceuticals. More on Pharmaceuticals Ultrasector Profund
Pharmaceuticals Ultrasector Profund [PHPIX] is traded in USA and was established 21st of December 2025. Pharmaceuticals Ultrasector is listed under ProFunds category by Fama And French industry classification. The fund is listed under Trading--Leveraged Equity category and is part of ProFunds family. This fund at this time has accumulated 4.29 M in assets with no minimum investment requirementsPharmaceuticals Ultrasector is currently producing year-to-date (YTD) return of 2.11% with the current yeild of 0.01%, while the total return for the last 3 years was -5.14%.
Check Pharmaceuticals Ultrasector Probability Of Bankruptcy
Instrument Allocation
Top Pharmaceuticals Ultrasector Profund Mutual Fund Constituents
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.